脑小血管病脑白质高信号危险因素相关性分析

Abstract
Figure/Table
References
Related Citation (7)

Download: PDF (2572 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the risk factors of white matter hyperintensities (WMHs) in Cerebral small vessel disease (CSVD) , and to further establish an early prediction model. Method A total of 233 patients hospitalized in Hunan Provincial People's Hospital were selected for retrospective analysis. According to the T2 sequence of head magnetic resonance plain scan to identify WMHs, they were divided into the observation group of 187 cases with WMHs and the control group of 46 cases without WMHs. The general data and related biochemical indicators of the two groups of patients in the training set were compared between the two groups, and the difference factors were analyzed by multivariate Logistic regression analysis. The receiver operating characteristic (ROC) curve was drawn for single and multiple independent risk factors, and a nomogram was constructed to establish a prediction model, and the predictive efficacy of the model was evaluated. Results There were significant differences in age, hypertension, coronary heart disease, monocyte count, blood urea nitrogen (BUN) , serum creatinine (SCr) , and glomerular filtration rate (eGFR) between the two groups of patients in the training set (P<0.05) . Multivariate regression analysis of 7 indicators showed that hypertension and SCr level were independent risk factors for WMHs. The area under the ROC curve of hypertension, SCr and the two indexes combined to predict WMHs was 0.655, 0.680 and 0.762, respectively. By constructing a nomogram for hypertension and SCr, the efficacy of the prediction model and the ROC curve of WMHs in the hypertension and SCr diagnostic validation set alone was evaluated, and the curve area was 0.763, 0.708, and 0.649, respectively. Conclusions Hypertension and SCr are independent risk factors for WMHs, and have predictive value for WMHs. The combination of hypertension and SCr is better than single index in predicting the risk of WMHs, which has guiding value for the early diagnosis of WMHs.

Key words： white matter hyperintensity risk factors serum creatinine monocyte

Received: 25 July 2023

PACS:

R743.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SU Qiyan
	HUANG Biao
	HU Aili
	PAN Hong
	HU Chongyu

Cite this article:

SU Qiyan,HUANG Biao,HU Aili等. Correlation analysis of risk factors for white matter hyperintensities in cerebral small vessel disease[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2024, 21(1): 66-71.

URL:

http://yxb.hunnu.edu.cn/EN/ OR http://yxb.hunnu.edu.cn/EN/Y2024/V21/I1/66

[1] SAWYER RP, WORRALL BB, HOWARD VJ, et al.Methods of a Study to Assess the Contribution of Cerebral Small Vessel Disease and Dementia Risk Alleles to Racial Disparities in Vascular Cognitive Impairment and Dementia[J]. J Am Heart Assoc, 2023, 12(17) : e030925.
[2] WANG T, JIN A, FU Y, et al.Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease[J]. Front Immunol, 2021, 12: 803504.
[3] LAM BYK, CAI Y, AKINYEMI R, et al.The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis[J]. Int J Stroke, 2023, 18(1) : 15-27.
[4] ZHANG F, PING Y, JIN X, et al.White matter hyperintensities and post-stroke depression: A systematic review and meta-analysis[J]. J Affect Disord, 2023, 320: 370-380.
[5] DEBETTE S, MARKUS HS.The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis[J]. Bmj, 2010, 341: c3666.
[6] GAO Y, LI D, LIN J, et al.Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets[J]. Front Aging Neurosci, 2022, 14: 961661.
[7] CHOJDAK-ŁUKASIEWICZ J, DZIADKOWIAK E, ZIMNY A, et al. Cerebral small vessel disease: A review[J]. Adv Clin Exp Med, 2021, 30(3) : 349-56.
[8] LITAK J, MAZUREK M, KULESZA B, et al.Cerebral Small Vessel Disease[J]. Int J Mol Sci, 2020, 21(24) : 9729.
[9] 胡文立, 杨磊, 李譞婷, 等. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(07) : 716-726.
[10] ROUHL RP, DAMOISEAUX JG, LODDER J, et al.Vascular inflammation in cerebral small vessel disease[J]. Neurobiol Aging, 2012, 33(8) : 1800-1806.
[11] MONTI D, OSTAN R, BORELLI V, et al.Inflammaging and human longevity in the omics era[J]. Mech Ageing Dev, 2017, 165(Pt B) : 129-138.
[12] FRANCESCHI C, GARAGNANI P, VITALE G, et al.Inflammaging and 'Garb-aging'[J]. Trends Endocrinol Metab, 2017, 28(3) : 199-212.
[13] PLAZA-ZABALA A, SIERRA-TORRE V, SIERRA A.Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging[J]. Int J Mol Sci, 2017, 18(3) : 598.
[14] KASHANI K, ROSNER MH, OSTERMANN M.Corrigendum to 'Creatinine: From physiology to clinical application'[European Journal of Internal Medicine 72C (2020) 9-14][J]. Eur J Intern Med, 2023, 116: 168-169.
[15] 杨磊磊, 彭夫松, 王保平. 肾功能指标联合检测对老年原发性高血压患者早期肾损伤的诊断价值[J]. 国际检验医学杂志, 2018, 39(13) : 1640-1642.
[16] Maciel AT.Back to Basics: Is There a Good Reason to Not Systematically Measure Urine Creatinine in Acute Kidney Injury Monitoring?[J]. Nephron, 2016, 133(2) : 111-115.
[17] 胡秀红, 杨洪娟, 王会卿, 等. 胱抑素C、肾损伤分子-1、血肌酐在先天性心脏病体外循环术所致急性肾损伤早期预警中的临床价值[J]. 中国现代医学杂志, 2016, 26(05) : 31-35.
[18] BAGHERI B, RADMARD N, FAGHANI-MAKRANI A, et al.Serum Creatinine and Occurrence and Severity of Coronary Artery Disease[J]. Med Arch, 2019, 73(3) : 154-156.
[19] ONAT A, YÜKSEL H, CAN G, et al. Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders[J]. Scand J Clin Lab Invest, 2013, 73(7) : 569-575.
[20] CHEN X, JIN H, WANG D, et al.Serum creatinine levels, traditional cardiovascular risk factors and 10-year cardiovascular risk in Chinese patients with hypertension[J]. Front Endocrinol (Lausanne) , 2023, 14: 1140093.
[21] 杨诗保. 脑卒中急性期血糖尿素氮肌酐水平与预后关系[J]. 现代医药卫生, 2011, 27(04) : 539-540.
[22] 徐丽华, 冀瑞俊, 高素颖, 等. 急性脑梗死患者1年预后不良的相关危险因素分析[J]. 临床荟萃, 2020, 35(10) : 895-899.
[23] AHMED M, SAHA R, ALAM I, et al.Serum Creatinine as Predictor Of Outcome in Hospitalized Patients After Acute Stroke[J]. Journal of Dhaka Medical College, 2023, 30(1) : 16-23.
[24] SAKAI S, HAGII J, SHIKANAI S, et al.Low Creatinine Clearance Is a Risk Factor for Severe Cardioembolic Stroke in Japanese Female Patients[J]. In Vivo, 2023, 37(1) : 336-344.
[25] LI M, CHENG A, SUN J, et al.The role of urinary albumin-to-creatinine ratio as a biomarker to predict stroke: A meta-analysis and systemic review[J]. Brain Circ, 2021, 7(3) : 139-46.
[26] 陈雯丽. 尿微量白蛋白/尿肌酐比值与急性脑梗死的相关性分析 [D]. 沈阳: 中国医科大学, 2021.
[27] 刘莹. 血清胱抑素C和尿微量白蛋白/肌酐比值与急性脑梗死的相关性分析 [D]. 大连: 大连医科大学, 2020.
[28] 曹建霞. 尿白蛋白/肌酐比值对急性脑梗死患者神经功能恶化的预测价值 [J]. 大同: 山西大同大学学报 (自然科学版) , 2019, 35 (01): 50-52+77.
[29] 李莎莎, 陈会生. 血尿素氮/肌酐比值和尿比重与急性脑梗死静脉溶栓预后的相关性研究[J]. 解放军医药杂志, 2016, 28(03) : 22-25.
[30] GONG Y, TIAN X, ZHOU Y, et al.Association between serum uric acid to serum creatinine ratio and poor functional outcomes in patients with acute ischemic stroke[J]. Eur J Neurol, 2022, 29(11) : 3307-3316.
[31] PENG R, LIU K, LI W, et al.Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort[J]. Atherosclerosis, 2021, 333: 1-8.
[32] 黄宽宽, 黄珊, 恽文伟, 等. 老年轻型卒中患者的肾功能与脑小血管病总负荷相关性分析[J]. 中华老年医学杂志, 2021, (07) : 831-835.
[33] VILAR-BERGUA A, RIBA-LLENA I, RAMOS N, et al.Microalbuminuria and the Combination of MRI Markers of Cerebral Small Vessel Disease[J]. Cerebrovasc Dis, 2016, 42(1-2) : 66-72.
[34] 刘翠梅. 脑白质疏松症危险因素的相关分析研究 [D]. 苏州: 苏州大学, 2016.
[35] LIU X, SUN P, YANG J, et al.Biomarkers involved in the pathogenesis of cerebral small-vessel disease[J]. Front Neurol, 2022, 13: 969185.
[36] DRÖGE W. Free radicals in the physiological control of cell function[J]. Physiol Rev, 2002, 82(1) : 47-95.
[37] KUPSCO A, SCHLENK D.Oxidative stress, unfolded protein response, and apoptosis in developmental toxicity[J]. Int Rev Cell Mol Biol, 2015, 317: 1-66.
[38] YAO Y, WANG Y, ZHANG Y, et al.Klotho ameliorates oxidized low density lipoprotein (ox-LDL) -induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways[J]. Lipids Health Dis, 2017, 16(1) : 77.
[39] BAI T, YU S, FENG J.Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease[J]. Front Neurol, 2022, 13: 861714.
[40] ITO S, NAGASAWA T, ABE M, et al.Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk[J]. Hypertens Res, 2009, 32(2) : 115-121.
[41] MOGI M, HORIUCHI M.Clinical Interaction between Brain and Kidney in Small Vessel Disease[J]. Cardiol Res Pract, 2011, 2011: 306189.
[42] TOYODA K.Cerebral small vessel disease and chronic kidney disease[J]. J Stroke, 2015, 17(1) : 31-37.
[43] TOYODA K, NINOMIYA T.Stroke and cerebrovascular diseases in patients with chronic kidney disease[J]. Lancet Neurol, 2014, 13(8) : 823-833.